when was semaglutide patented China's weight-loss drug makers take on global giants as Novo Nordisk patent expires The Semaglutide Patent Puzzle: Evergreening

Tailored nutritional and therapeutic strategies may enhance efficacy and minimise AEs, highlighting the need for a personalised, integrative approach

Exclusion criteria apply

Similar effects were observed when saxagliptin 5 mg and metformin HCl were coadministered in treatment-naive patients compared to placebo and metformin HCl

While not a quick fix, these medications can be a valuable part of a long-term weight loss strategy

Research Support and Efficacy Numerous clinical trials have demonstrated the effectiveness of semaglutide for weight loss: Clinical Trials : In a pivotal study involving approximately 2,000 adults with obesity or overweight (without diabetes), those using semaglutide in conjunction with lifestyle modifications lost an average of 14.9% of their body weight over 68 weeks, compared to a mere 2.4% weight loss in the placebo group

Research shows that approximately 20-30% of semaglutide users experience some form of gastrointestinal discomfort, with acid reflux ranking among the most common complaints during dose escalation phases